![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/113 | (2010.01) |
A61K 47/549 | (2017.08) | ||
A61K 31/713 | (2006.01) | ||
A61K 47/55 | (2017.08) | ||
C07H 21/00 | (2013.01) | ||
C12N 15/111 | (2013.01) | ||
C12N 15/113 | (2013.01) | ||
C12N2310/14 | (2013.01) | ||
C12N2310/351 | (2013.01) | ||
C12N2310/3519 | (2013.01) | ||
C12N2310/51 | (2013.01) | ||
C12N2320/31 | (2013.01) |
(11) | Number of the document | 3324980 |
(13) | Kind of document | T |
(96) | European patent application number | 16828302.6 |
Date of filing the European patent application | 2016-07-15 | |
(97) | Date of publication of the European application | 2018-05-30 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/042498 |
Date | 2016-07-15 |
(87) | Number | WO 2017/015109 |
Date | 2017-01-26 |
(30) | Number | Date | Country code |
201562194003 P | 2015-07-17 | US |
(72) |
JADHAV, Vasant , US
MAIER, Martin , US
ZLATEV, Ivan , US
AKINC, Akin , US
RAJEEV, Kallanthottathil G. , US
NAIR, Jayaprakash K. , US
KANDASAMY, Pachamuthu , US
MANOHARAN, Muthiah , US
|
(73) |
Alnylam Pharmaceuticals, Inc. ,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
(54) | MULTI-TARGETED SINGLE ENTITY CONJUGATES |
MULTI-TARGETED SINGLE ENTITY CONJUGATES |